Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 165, Issue 1, 2014, Pages 57-66

  Samuels, Amy L ^a   Heng, Jasmin Y ^a   Beesley, Alex H ^a   Kees, Ursula R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Acute lymphoblastic leukaemia; Glucocorticoid; Glycolysis; Metabolism; Resistance

Indexed keywords

ADENOSINE TRIPHOSPHATE; BERBERINE; CHOLESTEROL; DEOXYGLUCOSE; DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; OLIGOMYCIN; PIOGLITAZONE; SIMVASTATIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BIOENERGY; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG SENSITIZATION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA; UPREGULATION;

ACUTE LYMPHOBLASTIC LEUKAEMIA; GLUCOCORTICOID; GLYCOLYSIS; METABOLISM; RESISTANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GALACTOSE; GLUCOCORTICOIDS; GLYCOLYSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; METHYLPREDNISOLONE; MITOCHONDRIA; OLIGOMYCINS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SIGNAL TRANSDUCTION;

EID: 84896051361     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12727     Document Type: Article

References (49)

1. Andela, V.B., Altuwaijri, S., Wood, J. & Rosier, R.N. (2005) Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists. FEBS Letters, 579, 1765-1769.
2. Bachmann, P.S., Gorman, R., Papa, R.A., Bardell, J.E., Ford, J., Kees, U.R., Marshall, G.M. & Lock, R.B. (2007) Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Research, 67, 4482-4490.
3. Beesley, A.H., Palmer, M.L., Ford, J., Weller, R.E., Cummings, A.J., Freitas, J.R., Firth, M.J., Perera, K.U., de Klerk, N.H. & Kees, U.R. (2006) Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines. British Journal of Cancer, 95, 1537-1544.
4. Beesley, A.H., Weller, R.E., Senanayake, S., Welch, M. & Kees, U.R. (2009a) Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines. Leukemia Research, 33, 321-325.
5. Beesley, A.H., Firth, M.J., Ford, J., Weller, R.E., Freitas, J.R., Perera, K.U. & Kees, U.R. (2009b) Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism. British Journal of Cancer, 100, 1926-1936.
6. Ben Sahra, I., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., Gounon, P., Le Marchand-Brustel, Y., Giorgetti-Peraldi, S., Cormont, M., Bertolotto, C., Deckert, M., Auberger, P., Tanti, J.F. & Bost, F. (2010) Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Research, 70, 2465-2475.
7. Bishayee, A. (2009) Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer prevention research (Philadelphia, Pa.), 2, 409-418.
8. Cairns, R.A., Harris, I.S. & Mak, T.W. (2011) Regulation of cancer cell metabolism. Nature Reviews Cancer, 11, 85-95.
9. Chang, T.H. & Szabo, E. (2000) Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Research, 60, 1129-1138.
10. Cheng, G., Zielonka, J., Dranka, B.P., McAllister, D., Mackinnon, A.C. Jr, Joseph, J. & Kalyanaraman, B. (2012) Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Research, 72, 2634-2644.
11. Cheong, J.H., Park, E.S., Liang, J., Dennison, J.B., Tsavachidou, D., Nguyen-Charles, C., Wa Cheng, K., Hall, H., Zhang, D., Lu, Y., Ravoori, M., Kundra, V., Ajani, J., Lee, J.S., Ki Hong, W. & Mills, G.B. (2011) Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Molecular Cancer Therapeutics, 10, 2350-2362.
12. Chou, T.C. & Talalay, P. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55.
13. Dallas, P.B., Gottardo, N.G., Firth, M.J., Beesley, A.H., Hoffmann, K., Terry, P.A., Freitas, J.R., Boag, J.M., Cummings, A.J. & Kees, U.R. (2005) Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? BMC Genomics, 6, 59.
14. Dordelmann, M., Reiter, A., Borkhardt, A., Ludwig, W.D., Gotz, N., Viehmann, S., Gadner, H., Riehm, H. & Schrappe, M. (1999) Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood, 94, 1209-1217.
15. Eberhart, K., Renner, K., Ritter, I., Kastenberger, M., Singer, K., Hellerbrand, C., Kreutz, M., Kofler, R. & Oefner, P.J. (2009) Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis. Leukemia, 23, 2167-2170.
16. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. & Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology, 23, 7942-7950.
17. Gaynon, P.S. (2005) Childhood acute lymphoblastic leukaemia and relapse. British Journal of Haematology, 131, 579-587.
18. Hanahan, D. & Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
19. Heerdt, B.G., Houston, M.A., Anthony, G.M. & Augenlicht, L.H. (1998) Mitochondrial membrane potential (delta psi(mt)) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Research, 58, 2869-2875.
20. Heerdt, B.G., Houston, M.A. & Augenlicht, L.H. (2006) Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential. Cancer Research, 66, 1591-1596.
21. Holleman, A., Cheok, M.H., den Boer, M.L., Yang, W., Veerman, A.J., Kazemier, K.M., Pei, D., Cheng, C., Pui, C.H., Relling, M.V., Janka-Schaub, G.E., Pieters, R. & Evans, W.E. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. New England Journal of Medicine, 351, 533-542.
22. Hulleman, E., Kazemier, K.M., Holleman, A., VanderWeele, D.J., Rudin, C.M., Broekhuis, M.J., Evans, W.E., Pieters, R. & Den Boer, M.L. (2009) Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood, 113, 2014-2021.
23. Kawedia, J.D., Kaste, S.C., Pei, D., Panetta, J.C., Cai, X., Cheng, C., Neale, G., Howard, S.C., Evans, W.E., Pui, C.H. & Relling, M.V. (2011) Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood, 117, 2340-2347; quiz 2556.
24. Kees, U.R., Ford, J., Price, P.J., Meyer, B.F. & Herrmann, R.P. (1987) PER-117: a new human ALL cell line with an immature thymic phenotype. Leukemia Research, 11, 489-498.
25. Kees, U.R., Ford, J., Watson, M., Murch, A., Ringner, M., Walker, R.L. & Meltzer, P. (2003) Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease. Molecular Cancer Therapeutics, 2, 671-677.
26. Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., Wang, S., Wu, J., Li, Z., Liu, J. & Jiang, J.D. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine, 10, 1344-1351.
27. Konopleva, M. & Andreeff, M. (2002) Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies. Current Opinion in Hematology, 9, 294-302.
28. Lauten, M., Cario, G., Asgedom, G., Welte, K. & Schrappe, M. (2003) Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Haematologica, 88, 1253-1258.
29. Marroquin, L.D., Hynes, J., Dykens, J.A., Jamieson, J.D. & Will, Y. (2007) Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicological Sciences, 97, 539-547.
30. Mathupala, S.P., Ko, Y.H. & Pedersen, P.L. (2009) Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Seminars in Cancer Biology, 19, 17-24.
31. Mohanti, B.K., Rath, G.K., Anantha, N., Kannan, V., Das, B.S., Chandramouli, B.A., Banerjee, A.K., Das, S., Jena, A., Ravichandran, R., Sahi, U.P., Kumar, R., Kapoor, N., Kalia, V.K., Dwarakanath, B.S. & Jain, V. (1996) Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. International Journal of Radiation Oncology Biology Physics, 35, 103-111.
32. Moreno-Sanchez, R., Rodriguez-Enriquez, S., Marin-Hernandez, A. & Saavedra, E. (2007) Energy metabolism in tumor cells. FEBS Journal, 274, 1393-1418.
33. Moreno-Sanchez, R., Rodriguez-Enriquez, S., Saavedra, E., Marin-Hernandez, A. & Gallardo-Perez, J.C. (2009) The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells? BioFactors, 35, 209-225.
34. Owen, M.R., Doran, E. & Halestrap, A.P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. The Biochemical journal, 348, 607-614.
35. Patel, K.R., Scott, E., Brown, V.A., Gescher, A.J., Steward, W.P. & Brown, K. (2011) Clinical trials of resveratrol. Annals of the New York Academy of Sciences, 1215, 161-169.
36. Pazirandeh, A., Xue, Y., Okret, S. & Jondal, M. (2000) Glucocorticoid resistance in thymocytes from mice expressing a T cell receptor transgene. Biochemical and Biophysical Research Communications, 276, 189-196.
37. Pieters, R., den Boer, M.L., Durian, M., Janka, G., Schmiegelow, K., Kaspers, G.J., van Wering, E.R. & Veerman, A.J. (1998) Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants. Leukemia, 12, 1344-1348.
38. Pui, C.H. & Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166-178.
39. Rossignol, R., Gilkerson, R., Aggeler, R., Yamagata, K., Remington, S.J. & Capaldi, R.A. (2004) Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Research, 64, 985-993.
40. Samudio, I., Fiegl, M. & Andreeff, M. (2009) Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Research, 69, 2163-2166.
41. Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H. & Andreeff, M. (2010) Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. The Journal of clinical investigation, 120, 142-156.
42. Santos, C.R. & Schulze, A. (2012) Lipid metabolism in cancer. FEBS Journal, 279, 2610-2623.
43. Schmidt, S., Irving, J.A., Minto, L., Matheson, E., Nicholson, L., Ploner, A., Parson, W., Kofler, A., Amort, M., Erdel, M., Hall, A. & Kofler, R. (2006) Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB journal, 20, 2600-2602.
44. Singh, D., Banerji, A.K., Dwarakanath, B.S., Tripathi, R.P., Gupta, J.P., Mathew, T.L., Ravindranath, T. & Jain, V. (2005) Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme. Strahlentherapie und Onkologie, 181, 507-514.
45. Tennant, D.A., Duran, R.V. & Gottlieb, E. (2010) Targeting metabolic transformation for cancer therapy. Nature Reviews Cancer, 10, 267-277.
46. Tissing, W.J., Meijerink, J.P., Brinkhof, B., Broekhuis, M.J., Menezes, R.X., den Boer, M.L. & Pieters, R. (2006) Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. Blood, 108, 1045-1049.
47. Vander Heiden, M.G., Cantley, L.C. & Thompson, C.B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029-1033.
48. Warburg, O. (1956) On the origin of cancer cells. Science, 123, 309-314.
49. Wong, W.W., Dimitroulakos, J., Minden, M.D. & Penn, L.Z. (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia, 16, 508-519.